Celianne Bacon
Psychiatric/Mental Health · Grand Island, NENPI 1588265615
Payments from drug & device makers
Across 41 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$212
- Alkermes, Inc.$148
- Vanda Pharmaceuticals Inc.$126
- Sunovion Pharmaceuticals Inc.$108
- Otsuka America Pharmaceutical, Inc.$91
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$24
- plus $41 from 2 others
What the payments were for
- Food & beverage$750100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $212 |
| Alkermes, Inc. | 7 | $148 |
| Vanda Pharmaceuticals Inc. | 5 | $126 |
| Sunovion Pharmaceuticals Inc. | 7 | $108 |
| Otsuka America Pharmaceutical, Inc. | 5 | $91 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $19 |
How this compares
$750 in reported general payments places this provider in the 40th percentile of 255 psychiatric/mental health providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triazolam | 11 | $1,374 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 18 | $1,194 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 23 | $1,116 |
| Buspirone Hcl | 67 | $985 |
| Olanzapine | 46 | $982 |
| Aripiprazole | 38 | $957 |
| Duloxetine Hcl | 42 | $585 |
| Chlordiazepoxide Hcl | 16 | $439 |
| Clonazepam | 33 | $412 |
| Hydroxyzine Hcl | 26 | $404 |
| Gabapentin | 21 | $389 |
| Bupropion XlBupropion Hcl | 23 | $309 |
| Trazodone Hcl | 49 | $290 |
| Bupropion Hcl SrBupropion Hcl | 19 | $277 |
| Sertraline Hcl | 35 | $271 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Grand Island
- Sherry KropatschGrand Island$11K
- Ashley KennedyGrand Island$6K
- Chelsea JohnsonGrand Island$5K
- Linda BerryGrand Island$5K
- Jennifer MurrayGrand Island$4K
- Kylene SchroerGrand Island$3K
- Dacia OakesonHastings$32K
- Margaret Emersonla Vista$30K
- Janelle HillOmaha$24K
- Kristi BoseOmaha$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.